Why Evonik is cutting 3,200 more jobs as Europe’s chemical squeeze deepens

Evonik Industries AG (XETRA: EVK) will eliminate approximately 3,200 additional jobs worldwide between 2027 and the end of 2029 as the German speciality-chemicals group deepens its Tailor Made restructuring programme. Around 2,150 of the affected positions will be in Germany, while digitalisation, outsourcing and potential offshoring will support the organisational redesign. The new reductions follow roughly 2,800 positions already scheduled to disappear between October 2023 and the end of 2026, taking the combined workforce impact to about 6,000 roles across the two programmes. The strategic significance is that Evonik Industries is no longer treating weak chemical demand as a temporary cycle and is instead reshaping its cost base, production footprint and business portfolio for a structurally more competitive global market.

Why is Evonik extending its restructuring before the original programme has ended?

Evonik Industries is extending Tailor Made because the environment facing European chemical companies has not improved enough to justify retaining the existing organisational structure. Demand remains weak across several industrial end markets, while selling prices, foreign-exchange movements and lower capacity utilisation continue to place pressure on profitability.

The company’s first-quarter performance illustrates the problem. Adjusted EBITDA of €475 million exceeded internal expectations, but sales declined 9% to €3.43 billion. Sales volumes fell 2%, prices declined 1% and the adjusted EBITDA margin contracted to 13.9%.

Those figures show that Evonik Industries remains profitable, but profitability is being supported partly by internal efficiency rather than a broad market recovery. Management expects its second quarter to benefit from customer stockpiling and stronger methionine prices, but it has also warned that inflation, higher energy expenses and weaker consumption could affect the second half.

The original programme was designed to remove approximately 2,800 roles by the end of 2026. Around 1,000 positions are expected to disappear during 2026 alone. Announcing another 3,200 reductions before that process is complete indicates that management believes the previous cost target is no longer sufficient for the competitive conditions likely to prevail through the end of the decade.

The combined programmes are equivalent to almost one-fifth of Evonik Industries’ current workforce of approximately 31,000 people, although the reductions are being implemented over several years and against a changing employment base. This is therefore not an incremental adjustment. It is a redesign of how the company expects to operate.

What does the closure of Evonik’s polyester business reveal about European competitiveness?

Evonik Industries will discontinue its global polyester business during 2027 after concluding that it has no viable route to sustainable profitability. The operation generates annual revenue of approximately €150 million but has been unprofitable for several years.

The Witten production site in Germany, which employs 266 people, will close entirely. Another 45 positions will be removed in Marl, while 35 roles will be affected at the company’s Shanghai production facility.

The decision is strategically important because management examined alternatives before choosing closure. Evonik Industries had previously explored a potential sale, but the business’s structural disadvantages, shrinking market momentum and intense competition reduced the likelihood of finding an acceptable long-term solution.

Closing the business demonstrates greater portfolio discipline. Revenue is not automatically valuable when production fails to cover capital, energy, labour and maintenance costs. Continuing an unprofitable operation can preserve employment temporarily but gradually consumes funds that could support stronger businesses.

The closure also provides an uncomfortable signal for European industrial policy. Germany offers skilled employees, advanced infrastructure and deep chemical expertise, but producers face comparatively high energy costs, strict regulation and growing competition from lower-cost regions.

Evonik Industries is a speciality-chemicals producer rather than a basic commodity manufacturer, yet even speciality activities can become uneconomic when products lack sufficient differentiation or customers can obtain similar materials from lower-cost suppliers. The polyester exit suggests that innovation alone cannot protect every European production line.

Can digitalisation and outsourcing generate real productivity rather than shift costs elsewhere?

Evonik Industries expects much of the workforce reduction to come through greater efficiency, digitalisation and outsourcing. Management is also examining offshoring opportunities for selected activities.

Digital tools can improve procurement, demand forecasting, maintenance, laboratory analysis, customer service and administrative processing. Artificial intelligence may help employees analyse technical data, predict equipment failures and automate repetitive finance or reporting tasks.

However, a smaller payroll does not guarantee a lower operating cost. Work removed from the internal organisation may return through consultants, technology contracts, external service providers or temporary labour. The company must measure the total cost of each redesigned process rather than presenting employee reductions as the sole evidence of productivity.

Outsourcing can generate savings when external providers perform standardised services across a larger scale. It becomes less attractive when the work requires deep knowledge of Evonik Industries’ plants, products or customer relationships.

Offshoring creates another trade-off. Moving finance, information technology, procurement or support functions to lower-cost locations can reduce expenses, but longer communication chains may slow decisions and weaken accountability.

The strongest implementation would remove unnecessary work before reducing the number of people performing it. Automating a complicated process without simplifying it first merely allows the company to create confusion at impressive speed.

Evonik Industries must therefore identify which activities create customer, technical or safety value and which exist mainly because the organisation accumulated procedures over time. Technology should support a simpler operating model rather than conceal an unchanged one.

What financial problem is Evonik trying to solve through another 3,200 job cuts?

Evonik Industries generated €14.1 billion in revenue and adjusted EBITDA of €1.87 billion during 2025. Revenue declined 7%, while adjusted EBITDA also weakened as selling prices, currency effects and demand pressure affected the two major operating segments.

The company’s return on capital employed was only 6.1% in 2025, down from 7.1% in the previous year and well below its medium-term ambition of 11%. This gap explains why management cannot be satisfied with maintaining current earnings.

A business can generate positive EBITDA while still producing inadequate returns on the capital invested in factories, technology and working capital. Evonik Industries needs either stronger earnings from its asset base or a smaller asset and cost structure.

The group continues to target adjusted EBITDA of between €1.7 billion and €2 billion for 2026. The midpoint would be broadly stable against 2025 rather than evidence of a decisive recovery.

Management has previously targeted a €1 billion improvement in adjusted EBITDA by 2027 compared with 2023, split between internal growth and optimisation measures. The expanded restructuring increases the importance of cost savings within that equation because market growth remains uncertain.

The challenge is that restructuring charges, severance payments and system investments can delay the cash benefit. Evonik Industries must show investors a clear progression from announced roles to realised savings, improved margins and higher return on capital.

Without that bridge, repeated job reductions risk becoming evidence that the company is managing decline rather than creating a more competitive enterprise.

How will the restructuring affect Evonik’s dividend and capital-allocation priorities?

Evonik Industries has changed its dividend framework so that future distributions will be linked more closely to adjusted net income. Between 40% and 60% of adjusted net income is expected to be distributed, replacing the previous emphasis on maintaining a stable nominal dividend.

For 2025, shareholders approved a transitional dividend of €1 per share, down from €1.17. The reduction recognises that distributions need to reflect the company’s earnings capacity and investment requirements.

The new policy gives management more flexibility during the restructuring. Cash will be required for severance, technology implementation, plant changes and selected growth projects. Maintaining a dividend disconnected from earnings could increase debt or reduce strategic investment.

Evonik Industries reported free cash flow of €695 million in 2025 and €183 million during the first quarter of 2026. Cash generation remains positive, but lower earnings and restructuring payments will compete with dividends and capital expenditure.

The company expects capital expenditure of approximately €750 million during 2026. Spending includes next-generation technologies and projects intended to produce relatively quick returns.

Capital allocation should increasingly favour businesses with defensible margins, differentiated products and attractive growth opportunities. Operations that require repeated support without producing competitive returns should face closure, sale or further redesign.

Investors may accept a lower dividend if retained cash produces stronger long-term earnings. They will be less forgiving when distributions decline while restructuring fails to improve margins or return on capital.

Why is Germany carrying most of the employment impact from Evonik’s new plan?

Approximately two-thirds of the additional reductions will occur in Germany, even though Evonik Industries operates across more than 100 countries. The concentration reflects the company’s historic headquarters, manufacturing footprint and administrative structure.

Germany contains many of Evonik Industries’ largest sites, corporate functions and technical organisations. This creates more opportunities for organisational simplification, but it also means local communities will absorb a disproportionate share of the disruption.

The cuts affect business and administrative units rather than being confined to a single corporate function. Evonik Industries is likely to review management layers, central support activities, plant structures and processes that can be automated or provided externally.

The company has said the reductions will be implemented in a socially acceptable manner, with details negotiated with employee representatives. Likely mechanisms include retirement, voluntary departures, internal transfers and decisions not to refill vacancies.

Germany’s labour framework can reduce the severity of abrupt dismissals, but it may also extend the implementation period. This helps explain why the latest programme runs from 2027 through 2029.

The longer timetable gives employees and sites more time to adjust, but prolonged uncertainty can damage morale. Workers may not know whether their roles, teams or locations will remain part of the future organisation.

Competitors and industrial employers could use that uncertainty to recruit skilled chemical engineers, plant specialists and digital professionals. Evonik Industries must therefore protect critical talent while reducing overall headcount.

Could Evonik’s restructuring strengthen competitors or accelerate a wider chemical-sector reset?

Evonik Industries is not alone in reducing employment and production across Europe. BASF, Wacker Chemie, Lanxess, Dow Inc. and other producers have announced cost reductions, site reviews or portfolio changes as demand and energy economics weaken.

The cumulative effect matters more than any single programme. Repeated closures can reduce local supplier activity, contractor demand and specialised career opportunities. They can also weaken industrial clusters that depend on shared infrastructure and experienced labour.

However, consolidation may eventually improve industry economics. Closing structurally uncompetitive capacity can reduce oversupply and allow stronger plants to operate at better utilisation rates.

Evonik Industries could benefit if its remaining portfolio becomes more focused on businesses with higher barriers to entry. Animal nutrition, speciality additives, high-performance materials and healthcare applications can support better margins when technology, intellectual property and customer integration provide differentiation.

Competitors may also benefit by recruiting employees or taking customers from discontinued operations. Suppliers serving Witten, Marl and other affected units may need to diversify their customer base.

The broader strategic question is whether European companies can move fast enough toward specialised, low-carbon and technology-intensive chemistry before traditional operations become uneconomic. Evonik Industries’ restructuring is an attempt to improve that transition, but the scale of the cuts shows how little room remains for delay.

Why did Evonik shares rebound after initially falling on the restructuring announcement?

Evonik Industries shares fell by around 3% after the restructuring was announced on June 18, reflecting concern about the scale of the cuts and the difficult market conditions that made them necessary.

The stock then rebounded strongly on June 19, closing near €16.03. That left the shares approximately 1% higher over five trading sessions but around 8% lower than the May 19 close.

The 52-week range of approximately €12.49 to €18.43 places the stock between its annual extremes. Evonik Industries has recovered from the low, but the shares remain about 13% below the high.

The initial decline suggests that investors did not view workforce reduction as an automatic positive catalyst. A company rarely removes thousands of positions when its end markets are expanding rapidly and margins are comfortably improving.

The following rebound may indicate that investors recognised the potential for deeper structural savings or considered the initial reaction excessive. Market volatility around the announcement also reflects uncertainty over energy prices and European industrial activity.

Investor sentiment can therefore be described as cautious rather than uniformly negative. The dividend yield, cost programme and potential earnings recovery may attract value-oriented shareholders, while weak demand and repeated restructuring limit confidence.

The next major test will be the August 4 second-quarter results. Investors will examine whether the anticipated improvement materialises, how higher raw-material costs affect the outlook and whether management provides clearer savings targets for the extended programme.

What does Evonik’s restructuring mean for professionals and chemical-sector job seekers?

The restructuring will reduce broad employment opportunities across Evonik Industries, particularly in administrative, management and support functions affected by digitalisation, outsourcing or offshoring.

The polyester closure will directly affect production and technical roles in Witten, Marl and Shanghai. Employees with experience in polymer processing, quality control, maintenance and chemical operations may need to seek positions in adjacent chemical, pharmaceutical or advanced-material industries.

Evonik Industries will still recruit selectively. Its careers platform continues to advertise roles in plant operations, procurement, catalysts, environmental health and safety, customer service and speciality-chemical business development.

Skills tied to high-value businesses are likely to remain more resilient. These include chemical engineering, process safety, biotechnology, pharmaceutical excipients, catalysts, additive manufacturing, data analytics, industrial automation and predictive maintenance.

Industry estimates suggest chemical engineers in Germany may earn approximately €50,000 to €79,000 annually across common experience levels, with experienced specialists potentially exceeding €100,000. Chemical-plant operator compensation may range from roughly €44,000 for earlier-career workers to around €69,000 for experienced operators.

Data analysts may command approximately €43,500 to €58,000 at junior levels, while senior specialists can earn between €72,000 and €92,000. Compensation varies by region, qualifications, collective agreements, shift requirements and technical specialisation.

Job seekers should assess whether a role supports a business Evonik Industries is actively growing or one being managed mainly for cash and efficiency. Positions linked to innovation, healthcare, sustainable materials, automation and differentiated customer applications are likely to offer stronger long-term prospects.

What happens next if Evonik’s extended Tailor Made programme succeeds or fails?

If the programme succeeds, Evonik Industries could emerge with a lower fixed-cost base, fewer organisational layers and a portfolio concentrated around more profitable speciality-chemical businesses.

The company would be better positioned to benefit when industrial demand improves because additional revenue could generate stronger incremental margins. Higher cash conversion and return on capital could also support a more sustainable dividend.

Successful digitalisation could improve plant reliability, procurement and customer service while allowing Evonik Industries to manage the business with fewer administrative resources.

Failure would create a far more difficult scenario. The company could lose thousands of employees, close sites and incur restructuring expenses without materially improving profitability.

Outsourcing could reduce control, while offshoring might weaken service quality and internal expertise. Excessive workforce reductions could also leave remaining employees carrying unsustainable workloads.

If demand remains weak after the programme is completed, Evonik Industries may need to consider additional plant closures or portfolio sales. Another major restructuring after 2029 would suggest that the current programme treated symptoms rather than the underlying competitive problem.

Christian Kullmann’s strategy is therefore a bet that Evonik Industries can control its own cost structure even when it cannot control global demand, energy markets or Asian competition. The company has chosen to act before conditions improve. Investors and employees will now judge whether that action builds a stronger speciality-chemicals group or simply a smaller one.

What are the key takeaways from Evonik Industries’ extended restructuring plan?

• Evonik Industries will eliminate another 3,200 jobs between 2027 and the end of 2029.
• Around 2,150 of the new reductions will occur in Germany across business and administrative units.
• The programme follows approximately 2,800 roles already scheduled for removal between October 2023 and the end of 2026.
• Digitalisation, outsourcing and potential offshoring will become major elements of the new operating model.
• Evonik Industries will close its unprofitable polyester business, including the Witten production site.
• Weak demand, high European costs and stronger international competition are driving the deeper restructuring.
• The company must improve return on capital rather than merely protect short-term EBITDA.
• Evonik Industries shares remain below their 52-week high despite rebounding after the announcement.
• Chemical engineering, process safety, biotechnology, automation and analytics skills may remain more resilient than general administrative roles.
• The programme will be successful only if workforce reductions produce stronger margins, cash flow and competitiveness without damaging innovation or plant reliability.